Insilico Medicine leader shares AI-driven drug discovery insights in Shanghai and Dubai
Published . Updated .
This report is about pharma and health and AI and big tech.
Directly affected
- No company is named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “drug” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “drug” (pharma and health) in this story.
- QQQ Invesco QQQ+0.9% 30d
Invesco QQQ: it holds the big tech and AI names. Linked by “ai” (AI and big tech) in this story.
- FXI iShares China Large-Cap ETF-4.7% 30d
iShares China Large-Cap ETF holds stocks listed in China, which this story is about (“shanghai”).
- UAE iShares MSCI UAE ETF
iShares MSCI UAE ETF holds stocks listed in the UAE, which this story is about (“dubai”).
- LLY Eli Lilly and+19.1% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.
- JNJ Johnson & Johnson+1.9% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.
- PFE Pfizer+8.5% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| XLVPrices arriving within minutes | — | — | — | — | after close | after close | after close |
| XBIPrices arriving within minutes | — | — | — | — | after close | after close | after close |
| QQQ | -1.57% | +0.81% | base | -3.48% | after close | after close | after close |
| FXIPrices arriving within minutes | — | — | — | — | after close | after close | after close |
| UAEPrices arriving within minutes | — | — | — | — | after close | after close | after close |
| LLYPrices arriving within minutes | — | — | — | — | after close | after close | after close |
| JNJPrices arriving within minutes | — | — | — | — | after close | after close | after close |
| PFEPrices arriving within minutes | — | — | — | — | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Insilico Medicine leader shares AI-driven drug discovery insights in Shanghai and Dubai News-Medical
Source: News-Medical
This story
| Company | When | Move | Status |
|---|---|---|---|
| QQQ | that day | -3.48% | final price |
| QQQ | three days earlier | +0.81% | final price |
| QQQ | five days earlier | -1.57% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 35 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 52 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 70 days before publication. Filed 8 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“Insilico Medicine leader shares AI-driven drug discovery insights in Shanghai and Dubai” scores 12 out of 100. The score uses 1 sources.